VJHemOnc was official media partner of the NYC-Miami Myeloma MRD 2020 Virtual Meeting which took place on the 8th of October 2020 and was organized by MMRF & Memorial Sloan Kettering Cancer Center.
The meeting brought together leading experts in multiple myeloma who discussed the use of measurable residual disease (MRD) in clinical and trial settings, furthering our understanding of recent advances in the disease, and encouraging interactive discussion.
Watch the meeting on-demand below!
MRD in 2020: BMCTN consensus document
Luciano Costa, MD, University of Alabama at Birmingham